Company / Income Tax
ENANTA PHARMACEUTICALS INC Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.8M
FY2025
5-year range
-$28.6M / $2.8M
FY2021-FY2025
Trend
+751.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax changed +752% YoY in FY2025, a notable deviation from the 9-year average annual change of -129%.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -33.2%.
Increased from -$29M to $3M over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- +34.9%
- 5-Year CAGR
- -33.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -33.2%, indicating a declining trend.
- In FY2025, income tax increased 751.5% year-over-year.
- Peak income tax was recorded in FY2017.
- Lowest income tax in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8M | +751.5% |
| FY2024 | -$433.0K | +98.5% |
| FY2023 | -$28.6M | -2587.6% |
| FY2022 | $1.1M | +239.1% |
| FY2021 | -$826.0K | -103.9% |
| FY2020 | $21.2M | +129.1% |
| FY2019 | $9.2M | -15.2% |
| FY2018 | $10.9M | -76.6% |
| FY2017 | $46.5M | +406.3% |
| FY2016 | -$15.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026